Nestle BOOST Class Action Lawsuit Dismissed Despite FTC Settlement
By Kimberly Mirando
Nestlé has managed to get a false advertising class action lawsuit concerning its BOOST children’s drink dismissed, despite settling with the FTC over the same false ad charges.
The FTC reached the Nestle BOOST false advertising settlement in February 2011 after charging the company with making false and misleading ad claims that its BOOST Kid Essentials drinks with probiotics boosted children’s immune systems, prevented certain illnesses, sped up recovery and reduced their school absences.
  
Under the FTC BOOST settlement, Nestle agreed to stop making these advertising claims unless they are approved by the Food and Drug Administration and/or backed by competent and reliable scientific evidence.
Soon after the Nestle BOOST settlement was reached, multiple class action lawsuits were filed against the company alleging false advertising.
U.S. District Judge Faith S. Hochberg dismissed the consumer false ad class action lawsuit (Scheuerman v. Nestle Healthcare Nutrition, Inc.) on the grounds that the Plaintiffs’ failed to provide sufficient evidence for their false or misleading statement claims.
Instead of proving that Nestle lacked scientific evidence to support the advertising claim that BOOST Kid Essentials is “clinically shown” to provide the advertised health benefits, the Plaintiffs merely criticized the strength of Nestlé’s scientific support and could only show that the claims were not convincing or significant.
Nestle submitted over 40 scientific articles and studies to substantiate its “clinically shown” ad claims.
“Plaintiffs’ experts and its other facts all boil down to a claim that Nestle’s scientific support underlying its claim of ‘clinically shown’ health benefits is not as strong as it should be and do not substantiate those claims,” Judge Hochberg wrote. “While Plaintiffs’ experts take issue with the strength and significance of these studies, their criticisms do not satisfy Plaintiffs’ burden of demonstrating that the ‘clinically shown’ advertising claims are false or misleading.”
The case is Kurt Scheuerman, et al. v. Nestle Healthcare Nutrition, Inc., Case No. 10-cv-03684-FSH-PS, U.S. District Court, District of New Jersey.
Updated October 3rd, 2012
All class action and lawsuit news updates are listed in the Lawsuit News section of Top Class Actions
Top Class Actions Legal Statement